Tower Research Capital LLC (TRC) - AILERON THERAPEUTICS INC ownership

AILERON THERAPEUTICS INC's ticker is and the CUSIP is 00887A204. A total of 21 filers reported holding AILERON THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AILERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$10,703
-20.1%
3,864
+91.3%
0.00%
Q1 2024$13,393
+97.3%
2,020
-9.3%
0.00%
Q4 2023$6,787
-1.0%
2,226
-50.6%
0.00%
Q3 2023$6,854
+2.3%
4,509
+20.5%
0.00%
Q2 2023$6,698
+167350.0%
3,742
+12.9%
0.00%
Q1 2023$4
-20.0%
3,313
+37.8%
0.00%
Q4 2022$52,4040.00%
Other shareholders
AILERON THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 1,777,827$4,9251.86%
Cable Car Capital LLC 420,000$1,163,4001.23%
Prosight Management, LP 265,000$734,0500.22%
Kepos Capital LP 106,000$2940.11%
Nantahala Capital Management 464,367$1,286,2970.08%
GAGNON SECURITIES LLC 37,977$105,1960.02%
Senvest Management, LLC 230,895$575,6210.02%
Warberg Asset Management LLC 31,354$86,2240.01%
Sigma Planning Corp 126,225$349,6430.01%
Alyeska Investment Group, L.P. 540,000$1,495,8000.01%
View complete list of AILERON THERAPEUTICS INC shareholders